Microsoft Corp. today announced the launch of Microsoft Discovery, a new enterprise-grade artificial intelligence platform built to revolutionize the research and development process by embedding ...
A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory problems not just from COVID but influenza and other respiratory infections.